PLATFORM & PIPELINE

Based on good will, we continuously strive to innovate science
and technology to improve the quality of life of patients and their families.

PLATFORM & PIPELINE

Based on good will, we continuously strive to innovate science
and technology to improve the quality of life of patients and their families.

PIPELINE

INHOUSE Program
TA Target Indication Pipeline Proof of
Mechanism
Hit-to-Lead Lead Opt. Pre-clinical Clinical
Neurology Alzheimer’s disease ILM01
Tau Tauopathies ILM02
Immunology Myelin Debris Multiple Sclerosis ILM21
TNFα IBD ILM22
Early R&D Collaboration (based on GAIA Platform)
Partner Target Collaboration Model Design Production In vitro In vivo
Undisclosed Catalyze360-ExploR&D
US Biotech Undisclosed GAIA + Antibody
US Research
Institute
Multiple Targets GAIA + De-novo binder